Did you mean "hepatitis"?
ACP and the American Academy of HIV Medicine collaborate on new guide to hepatitis C testing | ACP Gastroenterology Monthly
The guide includes a summary of the latest testing recommendations; diagnostic, billing, and laboratory codes for testing; resources for referrals to HCV-experienced clinicians; and information on patient interactions, education, conversations, and
Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response | ACP Gastroenterology Monthly
A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.
This month's quiz asks readers to evaluate a 58-year-old man at a follow-up visit for hepatitis C-related cirrhosis complicated by nonbleeding small esophageal varices and ascites.
8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C | ACP Gastroenterology Monthly
The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
This month's quiz asks readers to determine appropriate management for a 55-year-old man with hepatitis C-related cirrhosis who is hospitalized for new-onset ascites.
Transplant of HCV-infected kidneys to HCV-negative recipients yields good outcomes at 12 months | ACP Gastroenterology Monthly
The study authors concluded that their results should encourage efforts to increase use of hepatitis C virus (HCV)-infected kidneys and called for larger confirmatory trials.
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
HCV-infected kidney transplants appear cost-effective in recipients with HCV | ACP Gastroenterology Monthly
Transplanting a hepatitis C virus (HCV)-infected kidney and then administering HCV treatment was more effective and cost less than transplanting an HCV-uninfected kidney after HCV treatment in HCV-infected patients, mainly because the waiting list
One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.